Call us today
(888) 584-0411

Former Catholic brother speaks out about church sex abuse scandal

NEW YORK — Allegations of sex abuse within the Catholic Church have been widespread for years, but it’s not often that someone from within the clergy talks about the problem.

May 15, 2019

New York Childhood Sexual Abuse Attorneys

NEW YORK — Allegations of sex abuse within the Catholic Church have been widespread for years, but it’s not often that someone from within the clergy talks about the problem.

Richard Cardillo is one of the few who will.

 

Read more here:

https://pix11.com/2019/05/09/former-catholic-brother-speaks-out-about-church-sex-abuse-scandal/

https://cision.criticalmention.com/app/#/clip/public/8e7a335b-16ac-4aba-9d18-3b58cb9c472e

 

Related News

October 30, 2026
Seeger Weiss Named Litigation Department of the Year for Products Liability and Mass Torts at the 2026 New Jersey Legal Awards

New Jersey-based Seeger Weiss has been named Litigation Department of the Year in the Products Liability and Mass Torts category at the New Jersey Law Journal’s 2026 New Jersey Legal Awards. Winners were announced on October 29, 2026, at The Palace at Somerset Park in Somerset, New Jersey. Over the past year, the department took […]

Read More
October 25, 2026
Seeger Weiss Partner Christopher A. Seeger Receives Inaugural Monroe E. Price Award from the Benjamin N. Cardozo School of Law

Seeger Weiss Partner Christopher Seeger received the inaugural Monroe E. Price Award from the Benjamin N. Cardozo School of Law, his alma mater, at the school’s 50th Anniversary Gala at the Hall des Lumières in New York City on October 22, 2026. The award is named for Monroe Price, who served as Dean of Cardozo […]

Read More
October 23, 2026
Seeger Weiss’s Christopher A. Seeger Appointed Co-Lead Counsel in In re: Dupixent (Dupilumab) Products Liability Litigation

Seeger Weiss LLP is pleased to announce that Partner Christopher A. Seeger has been appointed Co-Lead Counsel in In re: Dupixent (Dupilumab) Products Liability Litigation, MDL No. 3180, pending in the U.S. District Court for the District of New Jersey. The litigation involves claims that Dupixent, an injectable biologic prescribed to treat inflammatory conditions including […]

Read More
↑